11:01 am Hemispherx Biopharma plans to file for regulatory approval of Ampligen to treat Chronic Fatigue Syndrome in three additional Latin American countries
View todays social media effects on HEB
View the latest stocks trending across Twitter. Click to view dashboard
See who Hemispherx is hiring next, click here to view
